Back

Obicetrapib and cardiovascular events

1 September 2025 (09:00 - 09:15)
Organised by: Logo
Congress Presentation Part of: Late-Breaking Clinical Science: lipids and cardiovascular risk Drug therapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Stephen Nicholls

Monash University, Melbourne (Australia)

5 More presentations in this session

Presentation thumbnail
LipoaScreen – cascade screening for lipoprotein(a)
Associate Professor J. Brinck (Stockholm, SE)
Slides
Presentation thumbnail
Triglyceride lowering after MI
Ms J. Schubert (Uppsala, SE)
Slides
Presentation thumbnail
NATURE-LEGACY: Long term legacy benefit of Lowering LDL and SBP
Professor B. Ference (Cambridge, GB)
Slides
Presentation thumbnail
GAELp(a): National Registry on Lp(a) and Cardiovascular Risk in Argentina
Doctor N. Renna (Mendoza, AR)
Slides
Presentation thumbnail
Carotid plaques stabilization and regression with evolocumab
Doctor T. Aranzulla (Turin, IT)
Slides

Access the full session

Session thumbnail
Late-Breaking Clinical Science: lipids and cardiovascular risk
Video

The Event

Event poster

ESC Congress 2025

1 September 2025 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Exploring the role of novel CETP inhibitors in lipid management
thumbnail
Congress Presentation
Safety and efficacy of obicetrapib in dyslipidemia: systematic review and meta-analysis
thumbnail
Congress Presentation
Novel oral LDL-c lowering therapies on the horizon: CETP inhibition

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources